INTERNATIONAL PATENT: ANAVEX LIFE SCIENCES CORP. FILES APPLICATION FOR "RESPONDER SELECTION AND TREATMENT WITH SIGMA-1 RECEPTOR THERAPY"

GENEVA, Jan. 20 -- ANAVEX LIFE SCIENCES CORP. (630 5th Avenue, 20th FloorNew York, New York 10111) filed a patent application (PCT/US2025/037005) for "RESPONDER SELECTION AND TREATMENT WITH SIGMA-1 RECEPTOR THERAPY" on Jul 09, 2025. With publication no. WO/2026/015656, the details related to the patent application was published on Jan 15, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MISSLING, Christopher U. (c/o Anavex Life Sciences Corp.630 5th Avenue, 20th FloorNew York, New York 10111)

Abstract: The present disclosure provides genes and genetic polymorphisms associated with an altered...